Frontage Announces Co-CEO Promotions

Posted 2025-01-13, ACCESSWIRE Headlines

EXTON, PA / ACCESSWIRE / January 13, 2025 / Frontage Holdings Corporation (SEHK stock code:1521) announced on January 6 2025 that Dr. Abdul Mutlib has decided to step aside from his current role as CEO of the company to facilitate the Company's leadership succession planning and that Chief Strategy Officer Dr. Wentao Zhang and... read full story

Ask about this article

Answer for your question of the article will be displayed here ...

Related News

Charles River Laboratories at the J.P. Morgan 43rd Annual Healthcare Conference Presentation (Charles River Laboratories International Inc)

Public Technologies 2025-01-14, 17:00

Coulter Partners places seasoned life sciences and CRO leader as CEO of Metrion Biosciences

Pharmiweb 2025-01-08, 10:46

ProteinQure Strengthens Leadership Team with Key Appointments to Accelerate Translational and Clinical Development Programs

ACCESSWIRE 2025-01-07, 16:24

Related News

Serna Bio Announces Scientific Advisory Board

PR Newswire
2025-01-10, 13:06

Champions Oncology Enhances Clinical Bioanalytical Services Portfolio with New Technology and Additional Leadership

ACCESSWIRE
2025-01-08, 16:44

Experienced Industry Leader Dr. Joerg Moeller Appointed as Chief Executive Officer of Antag Therapeutics

PR Newswire
2025-01-08, 08:50

TriSalus Announces Leadership Changes Form 8 K (Trisalus Life Sciences Inc)

Public Technologies
2025-01-08, 21:52

Professional Services Firm, Pariveda, Announces Board Leadership Transition

PR Newswire
2025-01-14, 11:14

MD Anderson Cancer Center Delegates Visit Vazyme Exploring Collaborative Research Opportunities

GetNews
2025-01-15, 17:21

Insilico Received Positive Topline Results from Two Phase 1 Trials of ISM5411, New Drug Designed Using Generative AI for the Treatment of Inflammatory Bowel Disease

PR Newswire
2025-01-07, 14:14

atai Life Sciences Announces Key Leadership Appointments as it Advances its Pipeline of Novel Psychedelic Therapeutics for Mental Health Form 8 K (ATAI Life Sciences NV)

Public Technologies
2025-01-10, 13:04